암 환자의 불면증과 수면장애, 어떻게 관리할 것인가?

키워드

참고문헌 (60)

1. Zabora J, "The prevalence of psychological distress by cancer site", Psychooncology, 10, pp.19~28 (2001)
2. Steel JL, "Depression, immunity, and survival in patients with hepatobiliary carcinoma", J Clin Oncol, 25, pp.2397~2405 (2007)
3. Franzen PL, "Sleep disturbances and depression : risk relationships for subsequent depression and therapeutic implications", Dialogues Clin Neurosci, 10, pp.473~481 (2008)
4. American Academy of Sleep Medicine, "The international classification of sleep disorders" (2001), AASM
5. Savard J, "Insomnia in the context of cancer : a review of a neglected problem", J Clin Oncol, 19, pp.895~908 (2001)
6. Palesh OG, "Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer:University of Rochester Cancer Center-Community Clinical Oncology Program", J Clin Oncol, 28, pp.292~298 (2010)
7. Park B, "Prevalence of insomnia among patients with the ten most common cancers in South Korea : health insurance review and assessment service-national patient sample", Sleep Med Res, 7, pp.48~54 (2016)
8. Berger AM, "Patterns of circadian activity rhythms and their relationships with fatigue and anxiety", depression in women treated with breast cancer adjuvant chemotherapy, 2010, pp.18, 105~114
9. Chung S, "Korean clinical practice guideline for management of insomnia in adults", Korean Neuropsychiatric Association, ~ (2019)
10. Garland SN, "Sleeping well with cancer : a systematic review of cognitive behavioral therapy for insomnia in cancer patients", Neuropsychiatr Dis Treat, 10, pp.1113~1124 (2014)
11. Ong J, "Utilizing cognitive-behavioral therapy for insomnia to facilitate discontinuation of sleep medication in chronic insomnia patients", Sleep Med Res, 3, pp.1~6 (2012)
12. Perlis ML, "Cognitive behavioral treatment of insomnia: a session-by-session guide" (2013), Koonja
13. Jacobs GD, "Say good night to insomnia: the six-week, drug-free program developed at Harvard medical school" (2004), KIOM
14. Korean Society of Sleep Medicine, "Cognitive behavioral treatment guidebook of insomnia" (2017), Korean Society of Sleep Medicine
15. Morin CM, "Cognitive-behavioral approaches to the treatment of insomnia", J Clin Psychiatry, 65(Suppl 16), pp.33~40 (2004)
16. Borbély AA, "A two process model of sleep regulation", Hum Neurobiol, 1, pp.195~204 (1982)
17. Parker KP, "Sleep", wake patterns of individuals with advanced cancer measured by ambulatory polysomnography, 2008, pp.26, 2464~2472
18. Bartsch C, "Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism", Cancer, 67, pp.1681~1684 (1991)
19. Berger AM, "Values of sleep", wake, activity, J Pain Symptom Manage, pp.2007, 33[DOI]
20. Youn S, "Cognitive-behavioral therapy for insomnia for cancer patients", Korean J Psycho-Oncol, 3, pp.1~10 (2017)
21. Zhou ES, "Adapting cognitive-behavior therapy for insomnia in cancer patients", Sleep Med Res, 8, pp.51~61 (2017)
22. Spielman AJ, "A behavioral perspective on insomnia treatment", Psychiatr Clin North Am, 10, pp.541~553 (1987)
23. Rumble ME, "Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast cancer survivors : a daily process analysis", Sleep, 33, pp.1501~1509 (2010)
24. Runowicz CD, "American Cancer Society", American Society of Clinical Oncology breast cancer survivorship care guideline, 2016, pp.34, 611~635
25. Graydon JE, "Fatigue-reducing strategies used by patients receiving treatment for cancer", Cancer Nurs, 18, pp.23~28 (1995)
26. Matthews EE, "Effects of exercise on sleep in women with breast cancer : a systematic review", Sleep Med Clin, 13, pp.395~417 (2018)
27. Soyoung Youn, "Time to Take Sleeping Pills and Subjective Satisfaction among Cancer Patients", PSYCHIATRY INVESTIGATION, 17(3), pp.249~255 (2020), 대한신경정신의학회[DOI]
28. Andrew BN, "The use of methylphenidate for physical and psychological symptoms in cancer patients : a review", Curr Drug Targets, 19, pp.877~887 (2018)
29. Chung S, "Sleeping pill administration time and patient subjective satisfaction", J Clin Sleep Med, 12, pp.57~62 (2016)
30. Chung S, "Assessment of cancer-related dysfunctional beliefs about sleep for evaluating sleep disturbance in cancer patients", Sleep Med Res, 8, pp.98~101 (2017)
31. Mortezaee K, "Boosting immune system against cancer by melatonin : a mechanistic viewpoint", Life Sci, 238, pp.116960~ (2019)
32. Jiao L, "Sleep duration and incidence of colorectal cancer in postmenopausal women", Br J Cancer, 108, pp.213~221 (2013)
33. Reiche EM, "Stress, depression, the immune system, and cancer", Lancet Oncol, 5, pp.617~625 (2004)
34. Nooner AK, "Using relaxation and guided imagery to address pain, fatigue, and sleep disturbances : a pilot study", Clin J Oncol Nurs, 20, pp.547~552 (2016)
35. Pachman DR, "Troublesome symptoms in cancer survivors : fatigue, insomnia, neuropathy, and pain", J Clin Oncol, 30, pp.3687~3696 (2012)
36. Mika J, "Neuronal and immunological basis of action of antidepressants in chronic painclinical and experimental studies", Pharmacol Rep, 65, pp.1611~1621 (2013)
37. Jameera Begam A, "Estrogen receptor agonists", antagonists in breast cancer therapy : a critical review, 2017, pp.71, 257~274
38. Marino JL, "Managing menopausal symptoms after cancer : an evidence-based approach for primary care", Med J Aust, 208, pp.127~132 (2018)
39. Chan CWH, "Pharmacogenomics of breast cancer : highlighting CYP2D6 and tamoxifen", J Cancer Res Clin Oncol, 146, pp.1395~1404 (2020)
40. Ramaswami R, "Venlafaxine in management of hot flashes in women with breast cancer : a systematic review and meta-analysis", Breast Cancer Res Treat, 152, pp.231~237 (2015)
41. Samuelsson LB, "Sleep and circadian disruption and incident breast cancer risk : an evidence-based and theoretical review", Neurosci Biobehav Rev, 84, pp.35~48 (2018)
42. Straif K, "Carcinogenicity of shift-work, painting, and fire-fighting", Lancet Oncol, 8, pp.1065~1066 (2007)
43. Stevens RG, "Considerations of circadian impact for defining ‘shift work’ in cancer studies : IARC Working Group report", Occup Environ Med, 68, pp.154~162 (2011)
44. Blask DE, "Melatonin, sleep disturbance and cancer risk", Sleep Med Rev, 13, pp.257~264 (2009)
45. Ward EM, "Carcinogenicity of night shift work", Lancet Oncol, 20, pp.1058~1059 (2019)
46. Lin X, "Night-shift work increases morbidity of breast cancer and all-cause mortality : a meta-analysis of 16 prospective cohort studies", Sleep Med, 16, pp.1381~1387 (2015)
47. Born J, "Effects of sleep and circadian rhythm on human circulating immune cells", J Immunol, 158, pp.4454~4464 (1997)
48. García-Mauriño S, "Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines", J Pineal Res, 29, pp.129~137 (2000)
49. Cos S, "Estrogen-signaling pathway : a link between breast cancer and melatonin oncostatic actions", Cancer Detect Prev, 30, pp.118~128 (2006)
50. Campos-Rodriguez F, "Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort", Am J Respir Crit Care Med, 187, pp.99~105 (2013)
51. Kendzerska T, "Obstructive sleep apnea and the prevalence and incidence of cancer", CMAJ, 186, pp.985~992 (2014)
52. Gozal D, "Sleep apnea and cancer : analysis of a nationwide population sample", Sleep, 39, pp.1493~1500 (2016)
53. Wang P, "Modeling the regulation of p53 activation by HIF-1 upon hypoxia", FEBS Lett, 593, pp.2596~2611 (2019)
54. Yttersian Sletta K, "Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts", PLoS One, 12, pp.e0183254~ (2017)
55. Friedman M, "The occurrence of sleep-disordered breathing among patients with head and neck cancer", Laryngoscope, 111, pp.1917~1919 (2001)
56. Ostacoli L, "Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy", Qual Life Res, 19, pp.531~537 (2010)
57. Aapro M, "Management of anaemia and iron deficiency in patients with cancer : ESMO clinical practice guidelines", Ann Oncol, 29, pp.iv96~iv110 (2018)
58. Tseng CM, "Adult narcoleptic patients have increased risk of cancer : a nationwide population-based study", Cancer Epidemiol, 39, pp.793~797 (2015)
59. Khan RB, "Prevalence, risk factors, and response to treatment for hypersomnia of central origin in survivors of childhood brain tumors", J Neurooncol, 136, pp.379~384 (2018)
60. Landolfi JC, "Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer : case study", Neuro Oncol, 5, pp.214~216 (2003)

관련 논문AI추천